Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation.

Mayne, Tracy J; Nordyke, Robert J; Schold, Jesse D; Weir, Matthew R; Mohan, Sumit

Mayne, Tracy J; Nordyke, Robert J; Schold, Jesse D; Weir, Matthew R; Mohan, Sumit.

Afiliación

Mayne TJ; Angion Biomedica, San Francisco, California, USA.
Nordyke RJ; Angion Biomedica, San Francisco, California, USA.
Schold JD; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Mohan S; Department of Medicine, Division of Nephrology, Vagelos College of Physicians & Surgeons and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.

Clin Transplant ; 35(7): e14326, 2021 07.

Article en En | MEDLINE | ID: mdl-33896052

Asunto(s)

Trasplante de Riñón; Tasa de Filtración Glomerular; Supervivencia de Injerto; Humanos; Riñón; Factores de Tiempo

Palabras clave

clinical trial design; glomerular filtration rate; graft survival; kidney (allograft)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón Tipo de estudio: Observational_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google